Geftrax-SB 1.5 Injection
Marketer
Geneda Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Geftrax-SB 1.5 Injection
Combiflox-1.5 Injection is a dual-action medication indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be solely under a physician's guidance; adherence to the prescribed schedule is crucial. Complete the full treatment course, even with symptom improvement, as premature cessation may compromise efficacy. Minor adverse effects may include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic manifestations (e.g., rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your physician of any concurrent medications, and pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to optimal recovery. Monitoring via laboratory tests may be employed to assess treatment response.
Uses of Geftrax-SB 1.5 Injection
Infections caused by bacteria
Major Benefits of Geftrax-SB 1.5 Injection:
Administering this medication will be handled by your physician or their nursing staff; patient self-medication is strictly prohibited.
Common Side effects of Geftrax-SB 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Geftrax-SB 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Geftrax-SB 1.5 Injection works:
The injectable formulation Geftrax-SB 1.5 combines ceftriaxone, a broad-spectrum antibiotic, with sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thus boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Geftrax-SB 1.5 Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Geftrax-SB 1.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Geftrax-SB 1.5 Injection necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Geftrax-SB 1.5 Injection may induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Geftrax-SB 1.5 Injection administration to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should receive Geftrax-SB 1.5 Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate Geftrax-SB 1.5 Injection dose alteration; however, physician consultation is advised.
What if you forget to take Geftrax-SB 1.5 Injection :
Omit a Geftrax-SB 1.5 Injection dose? Seek your physician's advice.
Facts to Know About Geftrax-SB 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently